Progressive Supranuclear Palsy clinical trials at UCSD
2 in progress, 1 open to eligible people
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
open to eligible people ages 18 years and up
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.
San Diego, California and other locations
A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)
Sorry, in progress, not accepting new patients
This is a Phase 2a study to assess the safety and tolerability of TPN-101 patients with PSP.
La Jolla, California and other locations
Our lead scientists for Progressive Supranuclear Palsy research studies include Doug Galasko, MD Gabriel Leger, MD Irene Litvan, MD.